Apprentice at Illumina

Bengaluru, Karnataka, India

Illumina Logo
Not SpecifiedCompensation
Internship, Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Requirements

  • Bachelor's Degree (e.g., B.A., B.Com., B.Sc., BBA, B.Tech, etc.)/Degree in Engineering, IT, Finance, Business, Supply Chain, or related fields
  • Recent graduates or final-year students eligible under the Apprenticeship Act/NAPS/NATS
  • 2025 Graduates Only
  • No prior work experience required
  • Strong willingness to learn and adapt in a professional setting
  • Basic communication, problem-solving, and teamwork skills preferred
  • Preferred local candidates for Bengaluru location

Responsibilities

  • Support day-to-day operations and assist in assigned tasks under the guidance of experienced professionals
  • Learn and apply company-specific systems, processes, and tools
  • Support project teams with data entry, documentation, analysis, and reporting
  • Maintain accurate records of work completed progress
  • Follow all safety, quality, and compliance standards as per company and regulatory guidelines
  • Collaborate with team members and contribute to a productive and inclusive learning environment
  • Demonstrate curiosity, teamwork, and a proactive attitude in learning and task execution
  • Perform other related duties as assigned due to business needs

Skills

Data Entry
Documentation
Data Analysis
Reporting
Compliance

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI